Neuronal voltage-gated calcium channels: Brief overview of their function and clinical implications in neurology

Neurology

Volumn 74, Issue 16, 2010, Pages 1310-1315

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ARTICLE; BRAIN FUNCTION; CALCIUM TRANSPORT; ELECTRIC POTENTIAL; EPILEPSY; GENE EXPRESSION; HUMAN; NEUROLOGY; NEUROMUSCULAR SYNAPSE; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL GANGLION;

EID: 77951467323     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181da364b     Document Type: Article

References (26)

1. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 2000;16:521-555.
2. Dai S, Hall DD, Hell JW. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 2009;89:411-452.
3. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 2003;83: 117-161.
4. Dolphin AC. Calcium channel diversity: multiple roles of calcium channel subunits. Curr Opin Neurobiol 2009;19: 237-244.
5. IftincaMC, Zamponi GW. Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci 2009;30:32-40.
6. Khosravani H, Zamponi GW. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 2006;86:941-966.
7. Tomlinson SE, Hanna MG, Kullmann DM, Tan SV, Burke D. Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo. Clin Neuro-physiol 2009;120:1768-1776.
8. Shakkottai VG, Paulson HL. Physiologic alterations in ataxia: channeling changes into novel therapies. Arch Neurol 2009;66:1196-1201.
9. Haan J, Terwindt GM, van den Maagdenberg AM, Stam AH, Ferrari MD. A review of the genetic relation between migraine and epilepsy. Cephalalgia 2008;28:105-113.
10. Striessnig J, Koschak A. Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2 + channels with gene knockout models. Channels 2008;2: 233-251.
11. Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 2006;129:8-17.
12. Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 2009;32:249-256.
13. Llinas RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci USA 1999;96:15222-15227.
14. Chioza B, Nashef L, Asherson P, Makoff A. CACNA1A and P/Q-type calcium channels in epilepsy. Lancet 2002; 359:258.
15. Imbrici P, Jaffe SL, Eunson LH, et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 2004;127:2682-2692.
16. Escayg A, De Waard M, Lee DD, et al. Coding and non-coding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000;66:1531-1539.
17. Walter JT, Alvina K, Womack MD, Chevez C, Khoda-khah K. Decreases in the precision of Purkinje cell pace-making cause cerebellar dysfunction and ataxia. Nat Neurosci 2006;9:389-397.
18. Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004;62:1623-1625.
19. Liao YJ, Safa P, Chen YR, Sobel RA, Boyden ES, Tsien RW. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc Natl Acad Sci USA 2008;105:2705-2710.
20. Saegusa H, Matsuda Y, Tanabe T. Effects of ablation of N-and R-type Ca(2 +) channels on pain transmission. Neurosci Res 2002;43:1-7.
21. Bauer CS, Nieto-Rostro M, Rahman W, et al. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci 2009;29:4076-4088.
22. Lynch SS, Cheng CM, Yee JL. Intrathecal ziconotide for refractory chronic pain. Ann Pharmacother 2006;40:1293-1300.
23. Matthews EA, Bee LA, Stephens GJ, Dickenson AH. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur J Neurosci 2007;25:3561-3569.
24. Kim D, Park D, Choi S, et al. Thalamic control of visceral nociception mediated by T-type Ca2+ channels. Science 2003;302:117-119.
25. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamater-gic signaling in striatal medium spiny neurons. Trends Neurosci 2007;30:228-235.
26. Gadjanski I, Boretius S, Williams SK, et al. Role of n-type voltage-dependent calcium channels in autoimmune optic neuritis. Ann Neurol 2009;66:81-93.